Unique Dual‐Affinity Strategy for Specific Lipopolysaccharide Clearance in Sepsis Therapy: Peptide‐Conjugated Molecularly Imprinted Polymers via Emulsion Interfacial Polymerization

+-based hemoperfusion in a septic rabbit model confirmed significant therapeutic efficacy, remarkably reducing circulating LPS levels and mitigating organ damage. This material design overcomes the challenge of specific LPS clearance, offering substantial promise for transformative sepsis therapy.